This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sato, M. Articles by Yasuda, K. Search for Related Content PubMed PubMed Citation Articles by Sato, M. Articles by Yasuda, K.

Association between Serum Leptin Concentrations and Bone Mineral Density, and Biochemical Markers of Bone Turnover in Adult Men

Third Department of Internal Medicine, Gifu University School of Medicine (M.S., N.T., H.S., K.T., A.S., S.K., K.Yo., K.Ya.), and Department of Internal Medicine, Matsunami General Hospital (R.T., M.H.), Gifu 500-8705, Japan

Address all correspondence and requests for reprints to: Noriyuki Takeda, M.D., Third Department of Internal Medicine, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu 500-8705, Japan. E-mail: ntkd{at}cc.gifu-u.ac.jp

Abstract

Leptin, the product of the ob gene, has been shown to inhibit bone formation in mice. We addressed whether leptin has any role in the regulation of bone mineral density (BMD) in humans. Subjects were 221 adult men with a mean (±SD) age and body mass index of 52.1 ± 8.7 yr and 23.6 ± 2.8 kg/m². Serum leptin, carboxyterminal propeptide of type 1 procollagen (PICP; a marker of bone formation), and cross-linked carboxyterminal teleopeptide of type 1 collagen (a marker of bone resorption) were measured by RIA. BMD was assessed by single photon absorptiometry, and total fat mass was determined by bioimpedance analysis. BMD was inversely associated with serum leptin concentrations and total fat mass after adjustment for body weight. PICP, but not cross-linked carboxyterminal teleopeptide of type 1 collagen, was inversely correlated with serum leptin. These results may suggest that an increase in serum leptin reduces bone formation and decreases BMD in adult men. Leptin may be a regulator of BMD in humans.

This article has been cited by other articles:

				L. Richert, T. Chevalley, D. Manen, J.-P. Bonjour, R. Rizzoli, and S. Ferrari Bone Mass in Prepubertal Boys Is Associated with a Gln223Arg Amino Acid Substitution in the Leptin Receptor J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4380 - 4386. [Abstract] [Full Text] [PDF]

				J. B. Richards, A. M. Valdes, K. Burling, U. C. Perks, and T. D. Spector Serum Adiponectin and Bone Mineral Density in Women J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1517 - 1523. [Abstract] [Full Text] [PDF]

				R. Bajoria, S. R. Sooranna, and R. Chatterjee Type 1 Collagen Marker of Bone Turnover, Insulin-Like Growth Factor, and Leptin in Dichorionic Twins with Discordant Birth Weight J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4696 - 4701. [Abstract] [Full Text] [PDF]

				P. Crabbe, S. Goemaere, H. Zmierczak, I. Van Pottelbergh, D. De Bacquer, and J.-M. Kaufman Are serum leptin and the Gln223Arg polymorphism of the leptin receptor determinants of bone homeostasis in elderly men? Eur. J. Endocrinol., May 1, 2006; 154(5): 707 - 714. [Abstract] [Full Text] [PDF]

				R. Abou Samra, N. H. Baba, N. Torbay, L. Dib, and G. E.-H. Fuleihan High Plasma Leptin Is Not Associated with Higher Bone Mineral Density in Insulin-Resistant Premenopausal Obese Women J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2588 - 2594. [Abstract] [Full Text] [PDF]

				L. Fontana, J. L. Shew, J. O. Holloszy, and D. T. Villareal Low Bone Mass in Subjects on a Long-term Raw Vegetarian Diet Arch Intern Med, March 28, 2005; 165(6): 684 - 689. [Abstract] [Full Text] [PDF]

				S.-i. Kawachi, N. Takeda, A. Sasaki, Y. Kokubo, K. Takami, H. Sarui, M. Hayashi, N. Yamakita, and K. Yasuda Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Are Associated With Early Carotid Atherosclerosis Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 617 - 621. [Abstract] [Full Text] [PDF]

				H. Blain, A. Vuillemin, A. Blain, F. Guillemin, N. D. Talance, B. Doucet, and C. Jeandel Age-Related Femoral Bone Loss in Men: Evidence for Hyperparathyroidism and Insulin-Like Growth Factor-1 Deficiency J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2004; 59(12): 1285 - 1289. [Abstract] [Full Text] [PDF]

				C. M. Morberg, I. Tetens, E. Black, S. Toubro, T. I. A. Soerensen, O. Pedersen, and A. Astrup Leptin and Bone Mineral Density: A Cross-Sectional Study in Obese and Nonobese Men J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5795 - 5800. [Abstract] [Full Text] [PDF]

				J. N. Roemmich, P. A. Clark, C. S. Mantzoros, C. M. Gurgol, A. Weltman, and A. D. Rogol Relationship of Leptin to Bone Mineralization in Children and Adolescents J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 599 - 604. [Abstract] [Full Text] [PDF]